Related Experiment Video

Updated: Aug 16, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Acute diarrheal disease in children: epidemiology, prevention, and treatment

Penelope H Dennehy1

  • 1Division of Pediatric Infectious Diseases, Rhode Island Hospital, Providence, 02903, USA. pdennehy@lifespan.org

Infectious Disease Clinics of North America
|August 17, 2005
PubMed

Insights

Acute diarrhea in children is a major global health issue. Effective management requires assessing illness severity, identifying pathogens, and ensuring proper fluid and electrolyte balance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Diarrhea is a leading cause of child morbidity and mortality globally.
  • Etiology of acute diarrhea in children is diverse and location-dependent.
  • A broad spectrum of enteric pathogens is increasingly linked to diarrheal diseases.

Purpose of the Study:

  • To summarize key aspects of managing acute diarrhea in children.
  • To highlight the importance of clinical and epidemiological evaluation.
  • To guide diagnostic and therapeutic strategies for diarrheal illnesses.

Main Methods:

  • Clinical evaluation to determine illness severity and exposures.
  • Epidemiologic assessment to understand risk factors.
  • Selective diagnostic testing including cultures, toxin assays, and parasite studies.

Main Results:

  • Fluid and electrolyte replacement is critical for managing diarrheal illnesses.
  • Identifying the specific pathogen can inform treatment decisions.
  • Antimicrobial therapy should be administered judiciously based on diagnosis.

Conclusions:

  • Comprehensive evaluation is essential for effective diarrhea management in children.
  • Prompt and adequate fluid and electrolyte support is paramount.
  • Targeted diagnostic approaches and appropriate antimicrobial use are key.

More Related Videos

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...